Focus: Bloom Science is a 2024-founded biotech company in San Diego focused on microbiota-based drug discovery for neurology and ophthalmology indications. The company is in early-stage development with a single Phase 1 program.
Profile data last refreshed 15m ago · AI intelligence enriched 2w ago
Stable — net -4 jobs in 30d
0 added, 4 removed. Backfill posture.
Bloom Science is a high-risk, high-reward early-stage play best suited for scientists and operators willing to bet on a novel platform and accept significant uncertainty about long-term viability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Bloom Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Bloom Science's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo